Drug intelligence / Profile preview

psilocin

Development stage
Phase 1
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Administration
Oral, Intravenous
01

Overview

Psilocin is a naturally occurring substituted tryptamine alkaloid and the primary active metabolite of psilocybin, found in various species of psychedelic mushrooms. It acts as a serotonergic psychedelic and is responsible for the psychoactive effects experienced after ingestion of "magic mushrooms." Psilocin exerts its effects primarily by acting as a partial agonist at serotonin receptors—most notably the 5-HT2A receptor—with additional activity at other serotonin receptor subtypes such as 5-HT1A and 5-HT2C. This interaction leads to altered perception, mood changes, hallucinations, synesthesia, and changes in cognition. Psilocin is used recreationally and has been investigated for potential therapeutic applications in mental health disorders such as depression and anxiety[5][6][8]. It is usually administered orally but can also be taken intravenously.

Other names
psilocin4-hydroxy-N,N-dimethyltryptamine4-HO-DMT
02

Targets

HTR2C (5-hydroxytryptamine 2C receptor)HTR2A (Serotonin receptor 5-HT2A)HTR1A (Serotonin receptor 1A (5-hydroxytryptamine receptor 1A))

Beyond the preview

Go deeper on psilocin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on psilocin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call